Cover Image
市場調查報告書

萎縮型黃斑部病變:全球臨床實驗趨勢

Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 339400
出版日期 內容資訊 英文 98 Pages
訂單完成後即時交付
價格
Back to Top
萎縮型黃斑部病變:全球臨床實驗趨勢 Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H2, 2015
出版日期: 2015年07月31日 內容資訊: 英文 98 Pages
簡介

萎縮型黃斑部病變是視野中心漸漸難失明的慢性眼科疾病。

本報告提供萎縮型黃斑部病變臨床實驗相關之最新趨勢分析,提供您各地區主要國家的臨床實驗數量,彙整臨床實驗的各階段進展,實驗對象採用狀況,有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 萎縮型黃斑部病變
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:眼科疾病治療藥臨床實驗上萎縮型黃斑部病變的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:眼科疾病治療藥臨床實驗上萎縮型黃斑部病變的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

萎縮型黃斑部病變治療藥臨床實驗主要的參與企業

有潛力的藥劑

最新臨床實驗新聞

臨床實驗簡介

  • 主要企業臨床實驗概要
    • F. Hoffmann-La Roche Ltd.
    • Ocata Therapeutics, Inc.
    • Acucela Inc.
    • Pfizer Inc.
    • 大塚集團
    • Ophthotech Corp.
    • Healthcare of Today, Inc.
    • Allergan, Inc.
    • Allergan Plc
    • Alexion Pharmaceuticals, Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • University of California, Davis
    • Al-Azhar university
    • Azienda Ospedaliera Pisana
    • Dr. Lutfi Kirdar Kartal Training and Research Hospital
    • Indian Council of Medical Research
    • Kaplan Medical Center
    • National Eye Institute
    • University of Kentucky
    • University of Miami

5個有代表性的臨床實驗簡介

附錄

目錄
Product Code: GDHC2804CTIDB

GlobalData's clinical trial report, "Dry (Atrophic) Macular Degeneration Global Clinical Trials Review, H2, 2015" provides an overview of Dry (Atrophic) Macular Degeneration clinical trials scenario. This report provides top line data relating to the clinical trials on Dry (Atrophic) Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Dry (Atrophic) Macular Degeneration
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Dry (Atrophic) Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Dry (Atrophic) Macular Degeneration to Ophthalmology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Dry (Atrophic) Macular Degeneration
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials
  • Prominent Drugs
    • Latest Clinical Trials News on Dry (Atrophic) Macular Degeneration
      • Jul 20, 2015: StemCells Transplants First Patient in Phase II Clinical Trial for Dry Age-Related Macular Degeneration
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Ocata Therapeutics, Inc.
      • Clinical Trial Overview of Ocata Therapeutics, Inc.
      • Acucela Inc.
      • Clinical Trial Overview of Acucela Inc.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Otsuka Holdings Co., Ltd.
      • Clinical Trial Overview of Otsuka Holdings Co., Ltd.
      • Ophthotech Corp.
      • Clinical Trial Overview of Ophthotech Corp.
      • Healthcare of Today, Inc.
      • Clinical Trial Overview of Healthcare of Today, Inc.
      • Allergan, Inc.
      • Clinical Trial Overview of Allergan, Inc.
      • Allergan Plc
      • Clinical Trial Overview of Allergan Plc
      • Alexion Pharmaceuticals, Inc.
      • Clinical Trial Overview of Alexion Pharmaceuticals, Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • University of California, Davis
      • Clinical Trial Overview of University of California, Davis
      • Al-Azhar university
      • Clinical Trial Overview of Al-Azhar university
      • Azienda Ospedaliera Pisana
      • Clinical Trial Overview of Azienda Ospedaliera Pisana
      • Dr. Lutfi Kirdar Kartal Training and Research Hospital
      • Clinical Trial Overview of Dr. Lutfi Kirdar Kartal Training and Research Hospital
      • Indian Council of Medical Research
      • Clinical Trial Overview of Indian Council of Medical Research
      • Kaplan Medical Center
      • Clinical Trial Overview of Kaplan Medical Center
      • National Eye Institute
      • Clinical Trial Overview of National Eye Institute
      • University of Kentucky
      • Clinical Trial Overview of University of Kentucky
      • University of Miami
      • Clinical Trial Overview of University of Miami
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials by Region, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Countries, 2015*
  • Proportion of Dry (Atrophic) Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Dry (Atrophic) Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Dry (Atrophic) Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Ocata Therapeutics, Inc., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Acucela Inc., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Ophthotech Corp., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Healthcare of Today, Inc., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan, Inc., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Allergan Plc, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Alexion Pharmaceuticals, Inc., 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Al-Azhar university, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Pisana, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Lutfi Kirdar Kartal Training and Research Hospital, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Indian Council of Medical Research, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by Kaplan Medical Center, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by National Eye Institute, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Kentucky, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2015*

List of Figures

  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015*
  • Proportion of Dry (Atrophic) Macular Degeneration to Ophthalmology Clinical Trials, G7 Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Dry (Atrophic) Macular Degeneration to Ophthalmology Clinical Trials, E7 Countries (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Dry (Atrophic) Macular Degeneration Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Dry (Atrophic) Macular Degeneration Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top